News

The dual-acting dopamine and norepinephrine reuptake inhibitor is the first approved to treat excessive daytime sleepiness in adults with narcolepsy or obstructive sleep apnea.

Disease-modifying therapies for relapsing-remitting MS were shown to reduce risk of conversion to secondary progressive MS.

Until recently, there's been little providers or parents could do, beyond offering supportive care, to improve outcomes for children with SMA. But there is new hope.

Largest birth cohort study to date strengthens link between infant bronchiolitis and later respiratory disease.

A new study of more than 300000 women finds their may be a link between higher BMI at puberty and development of MS.

The applications seek FDA approval for blood sugar control and cardiovascular risk reduction in adults with type 2 diabetes.

Study finds that cardiovascular disease accounts for almost 40% of deaths in young adults with end-stage renal disease.

Little is known on the underlying pulmonary arterial lesions in patients with this phenotype of COPD.

How I became a doctor, lost sight of the joy of practice, and eventually regained my passion to serve my patients.

The 60-hour intravenous therapy becomes the first drug indicated for postpartum depression.

The oral immunotherapy seeks approval as a treatment to reduce the risk of anaphylaxis in peanut-allergic children and adolescents following exposure to peanut.

Eosinophilic asthma is characterized by elevated levels of eosinophils, which are a direct cause of chronic inflammation in severe asthma.

Flu tracking estimates that don’t consider behavioral differences between different demographic groups will tend to underestimate the spread of the flu, a new study reports.

Patients who received a flu shot had a lower rate of myocardial infarction, according to new research.

The Acticor and Rivacor brands from BIOTRONIK have become the smallest, slimmest 3 Tesla MR-conditional CRM devices on the US market.

FDA approved Rocklatan, a once-daily eye drop produced by Aerie Pharmaceuticals Inc., for patients with open-angle glaucoma or ocular hypertension.

Originally approved in 2013, the MitraClip is now approved for treating certain cases of secondary mitral regurgitation.

First prospective study of direct-acting antiviral treatment of HCV in cancer patients finds that it is safe, efficacious, and that it can open options for chemotherapy.

The Venovo venous stent is the first indicated to treat this condition.

Rehabilitative approaches seem promising for managing cognitive problems in multiple sclerosis.

How can emergency department doctors best be prepared to identify and treat seizures in the ER?

University of Colorado study finds choline can help prevent fetal brain development problems in expecting mothers who experience illness.

Physicians found bempedoic acid was capable of reducing LDL-C by another 18% without muscle or liver issues due to high-dose statin regimen.

A review of suicide prediction models reveals limited practical application on larger populations.

Pain management protocols for women undergoing C-sections, that include a non-opioid option such as EXPAREL, can help improve pain management and reduce the need for opioids.

New research suggests that in the era of disease-modifying therapies, women with multiple sclerosis face no heightened risks of relapse after pregnancy.

While the diseases appear to be unrelated, there may be underlying factors that link them together.

The National Cancer Institute director will assume temporary leadership after Scott Gottlieb, MD, departs next month.